Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Rift Valley Fever Virus can be transmitted from mother to foetus in rats
Foetal death occurred in pups from infected yet asymptomatic dams.
First study to discover vertical transmission in species other than livestock

A study, published on ‘Science Advances’, states that it is the first study to demonstrate fatal vertically transmitted infection with Rift Valley Fever Virus (RVFV) in a species other than livestock.

The research discovered direct placental infection with RVFV as a mechanism for vertical transmission and foetal demise in rats and suggests that the results now emphasise the possible impact of a future epidemic.

A pregnant rodent model was developed in the study in order to investigate how RVFV infection during pregnancy affects the foetus. It was found that infection in dams had a widespread viral distribution with preference for replication and tissue damage in the placenta; identifying direct placental infection as a mechanism for vertical transmission.

The study also found that the mortality rate of RVFV infection was greater in pregnant rats than non-pregnant rats, and that foetal death and significant congenital abnormalities occurred in pups from infected yet asymptomatic dams.

Pregnant women infected with RVFV has been associated with miscarriage. The researchers of this study state that their results suggest that even mild RVFV infection may still have a devastating impact on the developing foetus.

RVFV infection in humans results either from infected mosquitoes, or from contact with contaminated blood or organs with infected animals. To date, there have been known cases of human-to-human transmission of RVFV.    

The full study can be read here.



Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.